Restenosis – Medxy AI

Drug-Coated Balloons Superior to Bare-Metal Stents in Preventing Restenosis for High-Grade Intracranial Atherosclerosis

By MedXY 01/21/2026

A multicenter randomized controlled trial demonstrates that drug-coated balloons significantly reduce 6-month restenosis and 1-year recurrent ischemic events compared to bare-metal stents in patients with symptomatic high-grade intracranial stenotic disease.

Neurology news Radiology

Drug-Coated Balloons Outperform Bare-Metal Stents in Reducing Restenosis for Symptomatic Intracranial Stenosis

By MedXY 01/21/2026

A multicenter RCT demonstrates that drug-coated balloon (DCB) angioplasty significantly reduces 6-month restenosis and 1-year recurrent ischemic events compared to bare-metal stenting in patients with high-grade symptomatic intracranial atherosclerotic disease.

Cardiology news

The Achilles’ Heel of Left Main Bifurcation: Circumflex Ostium Remains the Primary Site of Restenosis Regardless of Stenting Strategy

By MedXY 01/18/2026

A subanalysis of the EBC MAIN trial reveals that the circumflex ostium is the most frequent site of restenosis following left main bifurcation stenting, occurring in 71% of patients requiring revascularization, regardless of whether a single- or dual-stent technique was employed.